This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name : 
Bioss
product type : 
antibody
product name : 
MAP3K8 Polyclonal Antibody
catalog : 
bs-3591R
quantity : 
100 ul
price : 
279 USD
clonality : 
polyclonal
host : 
rabbit
conjugate : 
nonconjugated
reactivity : 
human, mouse, rat
application : 
western blot, immunocytochemistry, immunohistochemistry - paraffin section
product information
sku : 
bs-3591R
name : 
MAP3K8 Polyclonal Antibody
category : 
Primary Antibody
conjugation : 
Unconjugated
host : 
Rabbit
target protein : 
MAP3K8
modification : 
Unmodified
clonality : 
Polyclonal
isotype : 
IgG
concentration : 
1ug/ul
public immunogen range : 
140-190/467
subcellular locations : 
Cytoplasm
source : 
KLH conjugated synthetic peptide derived from human MAP3K8
gene id link : 
Entrez Gene:  1326
swiss prot : 
P41279
swiss prot link : 
Swiss Prot:  P41279
applications : 
WB, IHC-P, IF(IHC-P)
applications with dilutions : 
WB(1:100-1000), IHC-P(1:100-500), IF(IHC-P)(1:50-200)
cross reactive species : 
Human, Mouse, Rat
size : 
100 ul
price : 
279 USD
background : 
Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.
purification : 
Purified by Protein A.
storage : 
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for 12 months.
synonyms : 
COT; EST; ESTF; TPL2; MEKK8; Tpl-2; c-COT; Mitogen-activated protein kinase kinase kinase 8; Cancer Osaka thyroid oncogene; Proto-oncogene c-Cot; Serine/threonine-protein kinase cot; Tumor progression locus 2; MAP3K8
lead time : 
3 to 5 business days.
company information
Bioss
500 West Cummings Park
Suite 6500
Woburn, MA 01801
Suite 6500
Woburn, MA 01801
info@biossusa.com
http://biossusa.com800-501-7654
headquarters: USA
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 antigens/primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications. Our company promises fast delivery with strong, top quality scientific support. Bioss Inc is located in the greater Boston area of Massachusetts, the center of the world's largest and fastest growing biotech community.
questions and comments
